Astrana Ev To Sales vs Capex To Operating Cash Flow Analysis

ASTH Stock

39.31 0.16 0.41%

Astrana Health financial indicator trend analysis is way more than just evaluating Astrana Health prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Astrana Health is a good investment. Please check the relationship between Astrana Health Ev To Sales and its Capex To Operating Cash Flow accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Astrana Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more detail on how to invest in Astrana Stock please use our How to Invest in Astrana Health guide.

Ev To Sales vs Capex To Operating Cash Flow

Ev To Sales vs Capex To Operating Cash Flow Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Astrana Health Ev To Sales account and Capex To Operating Cash Flow. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between Astrana Health's Ev To Sales and Capex To Operating Cash Flow is 0.55. Overlapping area represents the amount of variation of Ev To Sales that can explain the historical movement of Capex To Operating Cash Flow in the same time period over historical financial statements of Astrana Health, assuming nothing else is changed. The correlation between historical values of Astrana Health's Ev To Sales and Capex To Operating Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ev To Sales of Astrana Health are associated (or correlated) with its Capex To Operating Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capex To Operating Cash Flow has no effect on the direction of Ev To Sales i.e., Astrana Health's Ev To Sales and Capex To Operating Cash Flow go up and down completely randomly.

Correlation Coefficient

0.55

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Ev To Sales

The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.

Capex To Operating Cash Flow

Most indicators from Astrana Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Astrana Health current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Astrana Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more detail on how to invest in Astrana Stock please use our How to Invest in Astrana Health guide.The Astrana Health's current Selling General Administrative is estimated to increase to about 118.2 M, while Tax Provision is projected to decrease to under 22.8 M.

	2021	2022	2023	2024 (projected)
Cost Of Revenue	596.1M	944.7M	1.2B	1.2B
Total Revenue	773.9M	1.1B	1.4B	1.5B

Cost Of Revenue Total Revenue

Astrana Health fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Cash	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Short Long Term Debt Total	Short Term Debt	Property Plant And Equipment Net	Non Current Assets Total	Non Currrent Assets Other	Net Receivables	Inventory	Other Current Assets	Property Plant And Equipment Gross	Net Tangible Assets
Total Assets		0.92	0.94	0.94	0.12	0.86	0.55	0.96	0.99	0.64	0.77	0.94	0.98	0.96	0.99	0.48	0.9	0.73	0.77	0.99	0.65	0.94	-0.91	0.97	0.87	0.87
Other Current Liab	0.92		0.99	0.97	0.07	0.95	0.54	0.96	0.92	0.55	0.72	0.89	0.96	0.95	0.94	0.43	0.88	0.86	0.62	0.89	0.84	0.96	-0.76	0.88	0.82	0.94
Total Current Liabilities	0.94	0.99		0.96	0.1	0.92	0.59	0.96	0.94	0.56	0.72	0.91	0.96	0.96	0.95	0.43	0.89	0.87	0.61	0.91	0.83	0.95	-0.77	0.9	0.8	0.92
Total Stockholder Equity	0.94	0.97	0.96		0.05	0.97	0.45	0.99	0.95	0.6	0.74	0.92	0.99	0.96	0.97	0.48	0.9	0.78	0.74	0.9	0.79	0.96	-0.81	0.94	0.91	0.96
Net Debt	0.12	0.07	0.1	0.05		0.09	-0.31	0.01	0.18	0.03	0.03	0.39	0.02	0.29	0.2	0.05	0.47	0.44	-0.08	0.05	0.26	0.22	-0.22	0.18	-0.02	-0.07
Retained Earnings	0.86	0.95	0.92	0.97	0.09		0.32	0.95	0.88	0.58	0.7	0.88	0.93	0.92	0.91	0.49	0.88	0.79	0.67	0.8	0.84	0.94	-0.72	0.88	0.87	0.95
Accounts Payable	0.55	0.54	0.59	0.45	-0.31	0.32		0.52	0.5	0.29	0.38	0.38	0.52	0.47	0.46	0.15	0.31	0.4	0.34	0.62	0.26	0.36	-0.26	0.37	0.38	0.38
Cash	0.96	0.96	0.96	0.99	0.01	0.95	0.52		0.97	0.61	0.74	0.92	1.0	0.95	0.97	0.49	0.89	0.75	0.78	0.94	0.75	0.94	-0.82	0.95	0.92	0.95
Cash And Short Term Investments	0.99	0.92	0.94	0.95	0.18	0.88	0.5	0.97		0.63	0.75	0.97	0.98	0.98	1.0	0.49	0.94	0.76	0.78	0.97	0.68	0.95	-0.89	0.98	0.89	0.87
Common Stock Total Equity	0.64	0.55	0.56	0.6	0.03	0.58	0.29	0.61	0.63		0.51	0.59	0.61	0.59	0.62	0.72	0.55	0.38	0.57	0.64	0.37	0.57	-0.6	0.62	0.58	0.57
Common Stock Shares Outstanding	0.77	0.72	0.72	0.74	0.03	0.7	0.38	0.74	0.75	0.51		0.7	0.75	0.73	0.75	0.31	0.67	0.53	0.57	0.76	0.5	0.73	-0.72	0.75	0.66	0.71
Non Current Liabilities Total	0.94	0.89	0.91	0.92	0.39	0.88	0.38	0.92	0.97	0.59	0.7		0.92	0.99	0.97	0.48	0.99	0.82	0.71	0.9	0.73	0.95	-0.86	0.95	0.84	0.81
Other Stockholder Equity	0.98	0.96	0.96	0.99	0.02	0.93	0.52	1.0	0.98	0.61	0.75	0.92		0.96	0.98	0.48	0.89	0.75	0.77	0.95	0.74	0.95	-0.85	0.96	0.91	0.94
Total Liab	0.96	0.95	0.96	0.96	0.29	0.92	0.47	0.95	0.98	0.59	0.73	0.99	0.96		0.99	0.47	0.98	0.86	0.69	0.93	0.78	0.97	-0.85	0.95	0.85	0.87
Total Current Assets	0.99	0.94	0.95	0.97	0.2	0.91	0.46	0.97	1.0	0.62	0.75	0.97	0.98	0.99		0.49	0.95	0.78	0.76	0.96	0.71	0.97	-0.9	0.98	0.88	0.89
Common Stock	0.48	0.43	0.43	0.48	0.05	0.49	0.15	0.49	0.49	0.72	0.31	0.48	0.48	0.47	0.49		0.46	0.28	0.46	0.47	0.32	0.45	-0.46	0.49	0.48	0.46
Short Long Term Debt Total	0.9	0.88	0.89	0.9	0.47	0.88	0.31	0.89	0.94	0.55	0.67	0.99	0.89	0.98	0.95	0.46		0.87	0.65	0.85	0.78	0.94	-0.83	0.93	0.8	0.81
Short Term Debt	0.73	0.86	0.87	0.78	0.44	0.79	0.4	0.75	0.76	0.38	0.53	0.82	0.75	0.86	0.78	0.28	0.87		0.28	0.67	0.93	0.81	-0.57	0.73	0.54	0.74
Property Plant And Equipment Net	0.77	0.62	0.61	0.74	-0.08	0.67	0.34	0.78	0.78	0.57	0.57	0.71	0.77	0.69	0.76	0.46	0.65	0.28		0.76	0.24	0.68	-0.71	0.74	0.94	0.67
Non Current Assets Total	0.99	0.89	0.91	0.9	0.05	0.8	0.62	0.94	0.97	0.64	0.76	0.9	0.95	0.93	0.96	0.47	0.85	0.67	0.76		0.58	0.89	-0.9	0.94	0.84	0.84
Non Currrent Assets Other	0.65	0.84	0.83	0.79	0.26	0.84	0.26	0.75	0.68	0.37	0.5	0.73	0.74	0.78	0.71	0.32	0.78	0.93	0.24	0.58		0.76	-0.5	0.7	0.53	0.81
Net Receivables	0.94	0.96	0.95	0.96	0.22	0.94	0.36	0.94	0.95	0.57	0.73	0.95	0.95	0.97	0.97	0.45	0.94	0.81	0.68	0.89	0.76		-0.87	0.93	0.85	0.91
Inventory	-0.91	-0.76	-0.77	-0.81	-0.22	-0.72	-0.26	-0.82	-0.89	-0.6	-0.72	-0.86	-0.85	-0.85	-0.9	-0.46	-0.83	-0.57	-0.71	-0.9	-0.5	-0.87		-0.92	-0.76	-0.78
Other Current Assets	0.97	0.88	0.9	0.94	0.18	0.88	0.37	0.95	0.98	0.62	0.75	0.95	0.96	0.95	0.98	0.49	0.93	0.73	0.74	0.94	0.7	0.93	-0.92		0.85	0.88
Property Plant And Equipment Gross	0.87	0.82	0.8	0.91	-0.02	0.87	0.38	0.92	0.89	0.58	0.66	0.84	0.91	0.85	0.88	0.48	0.8	0.54	0.94	0.84	0.53	0.85	-0.76	0.85		0.85
Net Tangible Assets	0.87	0.94	0.92	0.96	-0.07	0.95	0.38	0.95	0.87	0.57	0.71	0.81	0.94	0.87	0.89	0.46	0.81	0.74	0.67	0.84	0.81	0.91	-0.78	0.88	0.85

Click cells to compare fundamentals

Astrana Health Account Relationship Matchups

Astrana Health fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	728.7M	817.5M	867.4M	966.2M	933.4M	980.0M
Other Current Liab	77.0M	74.1M	88.5M	128.5M	184.1M	193.3M
Total Current Liabilities	105.4M	115.0M	114.7M	148.6M	218.7M	229.6M
Total Stockholder Equity	191.5M	330.8M	448.2M	542.6M	614.2M	644.9M
Net Debt	153.3M	67.1M	(32.1M)	(58.7M)	27.2M	28.6M
Retained Earnings	31.9M	69.8M	137.2M	182.4M	243.1M	255.3M
Accounts Payable	6.9M	9.6M	5.5M	10.5M	9.1M	9.5M
Cash	103.3M	193.5M	233.1M	288.0M	293.8M	308.5M
Cash And Short Term Investments	219.8M	261.2M	286.5M	293.6M	296.3M	311.1M
Common Stock Total Equity	35.9K	42K	45K	47K	54.1K	30.0K
Common Stock Shares Outstanding	36.4M	37.4M	45.4M	45.6M	47.1M	49.4M
Liabilities And Stockholders Equity	728.7M	817.5M	867.4M	966.2M	933.4M	980.0M
Non Current Liabilities Total	262.2M	257.3M	242M	259.1M	303.9M	319.1M
Other Stockholder Equity	159.6M	261.0M	310.9M	360.1M	371.0M	389.6M
Total Liab	367.7M	372.3M	356.7M	407.7M	522.6M	548.7M
Total Current Assets	329.1M	338.6M	404.5M	428.1M	461.5M	484.6M
Common Stock	35.9K	42K	45K	47K	54.1K	33.4K
Short Long Term Debt Total	256.6M	260.6M	201.0M	229.4M	321.0M	337.1M
Short Term Debt	12.6M	14.2M	3.9M	4.8M	24.8M	26.0M
Property Plant And Equipment Net	26.4M	48.5M	68.6M	129.0M	44.6M	23.8M
Non Current Assets Total	399.6M	478.9M	462.9M	538.1M	471.9M	495.4M
Non Currrent Assets Other	1.7M	19.4M	5.9M	4.6M	44.6M	46.9M
Net Receivables	99.0M	60.6M	99.3M	119.7M	147.8M	155.1M
Other Current Assets	10.3M	16.8M	18.6M	14.8M	17.5M	18.3M
Property Plant And Equipment Gross	26.4M	48.5M	68.6M	129.0M	67.4M	70.8M
Net Tangible Assets	18.8M	119.0M	118.7M	214.0M	246.1M	258.4M
Current Deferred Revenue	8.9M	13.0M	16.8M	531K	744K	706.8K
Noncontrolling Interest In Consolidated Entity	786.2K	87K	5.9M	2.2M	2.5M	1.8M
Other Assets	2.4M	55.3M	6.5M	6.1M	22.1M	12.9M
Long Term Debt	232.2M	230.2M	182.9M	203.4M	258.9M	271.9M
Good Will	238.5M	239.1M	246.4M	269.1M	278.8M	139.8M
Retained Earnings Total Equity	31.9M	69.8M	143.6M	192.7M	221.6M	232.7M
Short Term Investments	116.5M	67.7M	53.4M	5.6M	2.5M	2.4M
Long Term Debt Total	232.2M	230.2M	182.9M	203.4M	233.9M	245.6M
Capital Surpluse	159.6M	261.0M	310.9M	360.1M	414.1M	434.8M
Deferred Long Term Liab	18.3M	11.0M	9.1M	3.0M	3.5M	6.8M
Intangible Assets	103.0M	87.0M	82.8M	76.9M	71.6M	56.4M

Currently Active Assets on Macroaxis

C	Citigroup
GM	General Motors
F	Ford Motor
GM	General Motors
V	Visa Class A

When determining whether Astrana Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Astrana Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Astrana Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Astrana Health Stock:

How To Invest In Astrana

Details

Is Astrana Stock a good investment?

Details

What is Astrana Health's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Astrana Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more detail on how to invest in Astrana Stock please use our How to Invest in Astrana Health guide.

You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Astrana Health. If investors know Astrana will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Astrana Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.30)

Earnings Share

1.3

Revenue Per Share

36.415

Quarterly Revenue Growth

0.375

Return On Assets

0.0449

The market value of Astrana Health is measured differently than its book value, which is the value of Astrana that is recorded on the company's balance sheet. Investors also form their own opinion of Astrana Health's value that differs from its market value or its book value, called intrinsic value, which is Astrana Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Astrana Health's market value can be influenced by many factors that don't directly affect Astrana Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Astrana Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Astrana Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Astrana Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Astrana Ev To Sales vs Capex To Operating Cash Flow Analysis

Ev To Sales vs Capex To Operating Cash Flow

Ev To Sales vs Capex To Operating Cash Flow Correlation Analysis

Correlation Coefficient

Ev To Sales

Capex To Operating Cash Flow

Astrana Health fundamental ratios Correlations

Astrana Health Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Astrana Health fundamental ratios Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Other Stockholder Equity	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash And Short Term Investments
Cash And Short Term Investments	+ 0.99	Total Assets
Total Current Assets	+ 0.99	Total Assets
Non Current Assets Total	+ 0.99	Total Assets
Total Current Liabilities	+ 0.99	Other Current Liab

Other Current Assets	- 0.92	Inventory
Inventory	- 0.91	Total Assets
Inventory	- 0.9	Non Current Assets Total
Inventory	- 0.9	Total Current Assets
Inventory	- 0.89	Cash And Short Term Investments
Inventory	- 0.87	Net Receivables